The platform offers compounded semaglutide and tirzepatide, and its highly personalized model allows for close monitoring, real-time dose adjustments, and a slower, microdose-friendly titration if needed
In the Phase 2 trial published in the New England Journal of Medicine (2023), retatrutide was administered as a once-weekly subcutaneous injection using a structured dose-escalation schedule
At 12 weeks, Semaglutide typically produces 5-6% weight loss
No, never adjust your GLP-1 dose without consulting your healthcare provider
You can then make an informed decision about whether the convenience trade-off (more frequent injections) is worth the pharmacokinetic benefit (more stable levels)
Thats why I, as a registered dietitian, have rounded up some easy, nutrient-packed recipes (plus our latest supplement) to help you fuel your body, balance blood sugar, and support your GLP-1 weight loss journey